Novogene (SHG: 688315)

Novogene is a corporation based in Beijing, China. Established in 2011, the company specializes in next-generation sequencing and bioinformatics services. It provides genomic solutions for research, clinical diagnostics, and pharmaceutical development. The company operates globally with facilities in Asia, Europe, and North America. The assets are managed by the executive team.